Literature DB >> 1654461

Human immunodeficiency virus Tat transactivation: induction of a tissue-specific enhancer in a nonpermissive cell line.

J Remenick1, M F Radonovich, J N Brady.   

Abstract

The enhancer of the human neurotropic papovavirus JC virus (JCV) restricts viral transcription to glial cells. We utilized the tissue specificity of the JCV enhancer as a tool to investigate the function of human immunodeficiency virus (HIV) Tat in transcriptional activation. The reporter plasmid pJCTAR-CAT was constructed by inserting the HIV type 1 Tat-responsive element, TAR, between the JCV promoter and the chloramphenicol acetyltransferase (CAT) gene. Cotransfection of pJCTAR-CAT and pSV-Tat, an expression vector for Tat, resulted in a 50-fold increase in JCV promoter activity in cells nonpermissive for JCV expression. Both the 98-bp JCV enhancer and the HIV TAR sequences were required for transactivation of pJCTAR-CAT in nonpermissive cells. The transactivation by Tat occurred at the level of transcription, as the increase in CAT activity paralleled an increase in the steady-state levels of CAT mRNA in S1 nuclease and nuclear run-on analyses. In the presence of Tat, the JCV enhancer is functional in cells normally nonpermissive for JCV expression; therefore, our results provide unique evidence that HIV type 1 Tat may regulate the activity of specific transcription factors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654461      PMCID: PMC249087     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat.

Authors:  J Hauber; B R Cullen
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.

Authors:  A I Dayton; J G Sodroski; C A Rosen; W C Goh; W A Haseltine
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

3.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.

Authors:  C A Rosen; J G Sodroski; W A Haseltine
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

5.  Transactivation induced by human T-lymphotropic virus type III (HTLV III) maps to a viral sequence encoding 58 amino acids and lacks tissue specificity.

Authors:  L J Seigel; L Ratner; S F Josephs; D Derse; M B Feinberg; G R Reyes; S J O'Brien; F Wong-Staal
Journal:  Virology       Date:  1986-01-15       Impact factor: 3.616

6.  Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat.

Authors:  M J Selby; E S Bain; P A Luciw; B M Peterlin
Journal:  Genes Dev       Date:  1989-04       Impact factor: 11.361

7.  The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.

Authors:  J Leonard; C Parrott; A J Buckler-White; W Turner; E K Ross; M A Martin; A B Rabson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  A discrete element 3' of human immunodeficiency virus 1 (HIV-1) and HIV-2 mRNA initiation sites mediates transcriptional activation by an HIV trans activator.

Authors:  A Jakobovits; D H Smith; E B Jakobovits; D J Capon
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

9.  Transcriptional but not translational regulation of HIV-1 by the tat gene product.

Authors:  A P Rice; M B Mathews
Journal:  Nature       Date:  1988-04-07       Impact factor: 49.962

10.  Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

Authors:  J A Garcia; D Harrich; E Soultanakis; F Wu; R Mitsuyasu; R B Gaynor
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  6 in total

Review 1.  [Progressive multifocal leukoencephalopathy].

Authors:  J C Wasmuth; A Wasmuth-Pietzuch; U Spengler; J K Rockstroh
Journal:  Med Klin (Munich)       Date:  1999-05-15

Review 2.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells.

Authors:  M O Westendorp; M Li-Weber; R W Frank; P H Krammer
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

4.  Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines.

Authors:  L Buonaguro; G Barillari; H K Chang; C A Bohan; V Kao; R Morgan; R C Gallo; B Ensoli
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1.

Authors:  T Lazzarotto; G Furlini; M C Re; E Ramazzotti; B Campisi; M P Landini
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 6.  Human polyomavirus reactivation: disease pathogenesis and treatment approaches.

Authors:  Cillian F De Gascun; Michael J Carr
Journal:  Clin Dev Immunol       Date:  2013-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.